ClearMed
AI in MedicineGuideline / Opinion2 min read

Beyond the Rogue Agent-Preparing Health Systems for AI Failure

Beyond the Rogue Agent investigated in a expert consensus / perspective + clinical ai evaluation at JAMA.

Published in JAMAExpert consensus / Perspective + Clinical AI evaluation
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

This Viewpoint discusses the role of artificial intelligence (AI) and health system preparedness and resilience in the event of an AI failure in clinical operations.

What Changes?

AI in Medicine · Guideline / Opinion

Current Standard

Conventional ai in medicine practice relies on standard-of-care monitoring and existing regimens prior to this expert consensus / perspective + clinical ai evaluation.

New Finding

Published in JAMA, these peer-reviewed ai in medicine findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    Delivered via beyond the Rogue Agent, this guideline and clinical review approach targets AI model.

  2. 02Study Evidence

    Tested in a expert consensus / perspective + clinical ai evaluation at the guideline and clinical review stage.

  3. 03Practical Meaning

    AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

What This Means for You

Published in JAMA, these peer-reviewed ai in medicine findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

The Discovery

This Viewpoint discusses the role of artificial intelligence (AI) and health system preparedness and resilience in the event of an AI failure in clinical operations.

How It Works, Simply

This ai in medicine research focuses on AI model. Researchers evaluated it using an expert consensus / Perspective + Clinical AI evaluation at the guideline and clinical review stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    Delivered via beyond the Rogue Agent, this guideline and clinical review approach targets AI model.

  2. 02Study Evidence

    Tested in a expert consensus / perspective + clinical ai evaluation at the guideline and clinical review stage.

  3. 03Practical Meaning

    AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

01

Biological Mechanism & Study Design

Study Design & Cohort

Expert consensus / Perspective + Clinical AI evaluation

Expert consensus / Perspective + Clinical AI evaluation · Guideline / Opinion

Biological Pathway & Modality

AI model

Intervention: Beyond the Rogue Agent

02

Experimental Findings & Endpoints

This Viewpoint discusses the role of artificial intelligence (AI) and health system preparedness and resilience in the event of an AI failure in clinical operations.

03

Clinical Translation & Practice Context

Published in JAMA, these peer-reviewed ai in medicine findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

03

The Bottom Line · Clinical Pearl

“This Viewpoint discusses the role of artificial intelligence (AI) and health system preparedness and resilience in the event of an AI failure in clinical operations.”

Published in JAMA · Current Stage: Guideline / Opinion

AI in Medicine · Guideline / Opinion
Study Type
Expert consensus / Perspective + Clinical AI evaluation

Expert consensus / Perspective + Clinical AI evaluation

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Expert consensus / Perspective + Clinical AI evaluation in ai in medicine care
Intervention & Mechanism
Beyond the Rogue Agent

AI model

Key Limitation
AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

Translational Stage

LEVEL 2 · Guideline / Opinion

Classified as Expert consensus / Perspective + Clinical AI evaluation along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Guideline / OpinionActive

Indexed Clinical Entities

Original Publication & AMA Citation

Beyond the Rogue Agent-Preparing Health Systems for AI Failure. JAMA. Published 2026;Nov 12. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/43018982/

JAMA

https://pubmed.ncbi.nlm.nih.gov/43018982/

Read Original Paper

Continue Reading

Related in AI in Medicine

View all AI in Medicine briefings →
AI in Medicine editorial photograph for ClinicalAge, a framework for modelling ageing trajectories from longitudinal electronic health records in the UK: a model development and validation study
AI IN MEDICINE · CLINICAL PRACTICE

ClinicalAge, a framework for modelling ageing trajectories from longitudinal electronic health records in the UK: a model development and validation study

Your Medical Records Could Reveal Your True 'Biological Age' — And Predict Your Health Future. A new AI tool, ClinicalAge, uses your existing health records to calculate your biological age, offering a powerful predictor of future health risks and lifespan.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readThe Lancet Digital Health
AI IN MEDICINE · CLINICAL PRACTICE

AI Enhances Bionic Vision Precision in Brain Implant Patient

An AI-powered system can precisely predict and generate personalized visual percepts in a blind individual with a brain implant by learning their unique cortical responses to electrical stimulation. Current bionic eye technologies, while offering some degree of visual perception, often struggle with precision, consistency, and the intuitive generation of meaningful visual information for the patient.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDaily
AI IN MEDICINE · PRECLINICAL

AI Discovers Natural Molecule for Obesity with Promising Side Effect Profile

AI-guided discovery of the natural molecule BRP offers a novel, potentially better-tolerated approach to obesity treatment than existing medications. BRP represents a potential 'Ozempic-like' treatment for obesity that may circumvent common digestive side effects and muscle loss often associated with current GLP-1 agonists.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDaily